Rx IP Update - June 2017

Published date29 June 2017
Law FirmSmart & Biggar
AuthorNancy Pei,Abigail Smith
Subject MatterMergers,Patents,Medical Marijuana,Appeals,Motion To Strike,International Litigation,Pharmacies,Personal Jurisdiction,Prescription Drugs,Section 8,GlaxoSmithKline,Leave to Appeal,Canada,Patent Infringement,Teva Pharmaceuticals,Competition Authorities,Apotex,Supreme Court of Canada,Product Labels,Health Canada,PMNOC Regulations,Patented Medicine Prices Review Board (PMPRB)

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT